Interferon therapy for preventing COPD exacerbations

Authors

  • Meenu Mehta Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia
  • Keshav R. Paudel Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW 2007, Australia
  • Shakti D. Shukla Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia
  • Madhur Shastri School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia
  • Sachin K. Singh School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • Monica Gulati School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • Harish Dureja Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
  • Gaurav Gupta School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India
  • Saurabh Satija Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • Philip M. Hansbro Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW 2007, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia
  • Dinesh K. Chellappan Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia
  • Kamal Dua Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia. Tel.: +61295147387, E-mail: Kamal.Dua@uts.edu.au

DOI:

https://doi.org/10.17179/excli2020-2997

Keywords:

interferons, COPD, cigarette smoking, viral infection, airway inflammation

Author Biography

Monica Gulati, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India

hof.lfams@lpu.co.in (e. email-Adresse)

Published

2020-11-04

How to Cite

Mehta, M. ., Paudel, K. R., Shukla, S. D., Shastri, M. ., Singh, S. K., Gulati, M. ., Dureja, H. ., Gupta, G. ., Satija, S. ., Hansbro, P. M., Chellappan, D. K., & Dua, K. (2020). Interferon therapy for preventing COPD exacerbations. EXCLI Journal, 19, 1477–1480. https://doi.org/10.17179/excli2020-2997

Issue

Section

Letters to the editor

Most read articles by the same author(s)

1 2 > >>